C0279
Carboxypeptidase Inhibitor from potato tuber
lyophilized powder
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
biological source
plant (white russett potato)
form
lyophilized powder
potency
1.1-6.0 nM Ki [CPB]
1.5-3.5 nM Ki [CPA]
mol wt
apparent mol wt 4.075-4.333 kDa
composition
Protein, ≥35% Lowry
solubility
water: soluble 5 mg/mL, clear
storage temp.
−20°C
Biochem/physiol Actions
Broad-spectrum inhibitor of carboxypeptidases of animal digestive-tract origin, but little or no activity against plant and microbial carboxypeptidases. However, recent results suggest it may play a part in resistance to microbial pathogens by preventing digestion of protein.
Packaging
Package size based on protein content
Unit Definition
One μg of inhibitor protein will inhibit the activity of ≥3 μg of carboxypeptidase A by 50% using hippuryl-L-phenylalanine as substrate at pH 7.5 at 25°C.
Physical form
Lyophilized powder containing traces of sodium citrate and sodium chloride; balance primarily non-protein components.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Purification and properties of a carboxypeptidase inhibitor from potatoes.
C A Ryan et al.
The Journal of biological chemistry, 249(17), 5495-5499 (1974-09-10)
Jarosław Króliczewski et al.
Scientific reports, 6, 34557-34557 (2016-10-05)
The cytochrome b
David Thompson et al.
The Journal of biological chemistry, 284(37), 24891-24903 (2009-07-11)
We have identified, purified, and characterized three subcomplexes of PA700, the 19 S regulatory complex of the 26 S proteasome. These subcomplexes (denoted PS-1, PS-2, and PS-3) collectively account for all subunits present in purified PA700 but contain no overlapping
Huaqi Tang et al.
Biotechnology and bioengineering, 118(3), 1405-1410 (2020-11-27)
Lack of experimental human models hinders research on Lassa hemorrhagic fever and the development of treatment strategies. Here, we report the first chip-based model for Lassa hemorrhagic syndrome. The chip features a microvessel interfacing collagen network as a simple mimic
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service